| Income Statement |
| Total Revenue | 2.68B |
|
| Revenues (USD) | 2.68B |
| Cost of Revenue | 581.00M |
| Gross Profit | 2.10B |
| Operating Expenses | 2.01B |
| Research and Development Expense | 638.00M |
| Selling, General and Administrative Expense | 1.05B |
| Operating Income | 86.00M |
| Income Tax Expense | 121.00M |
| Net Income | 160.00M |
| Net Income Common Stock | 160.00M |
| Net Income Common Stock (USD) | 160.00M |
| Consolidated Income | 160.00M |
| Earnings per Basic Share | 0.27 |
| Earnings per Basic Share (USD) | 0.27 |
| Earnings per Diluted Share | 0.26 |
| Earning Before Interest & Taxes (EBIT) | 281.00M |
| Earning Before Interest & Taxes (USD) | 281.00M |
| Weighted Average Shares | 598.00M |
| Weighted Average Shares Diluted | 608.00M |
| Balance Sheet |
| Cash and Equivalents | 7.04B |
| Cash and Equivalents (USD) | 7.04B |
| Investments | 4.97B |
| Investments Current | 4.97B |
| Trade and Non-Trade Receivables | 10.55B |
| Current Assets | 23.60B |
| Total Assets | 26.83B |
| Total Debt | 2.48B |
| Current Liabilities | 16.36B |
| Debt Non-Current | 2.48B |
| Total Liabilities | 19.19B |
| Accumulated Retained Earnings (Deficit) | -6.40B |
| Accumulated Other Comprehensive Income | -2.00M |
| Shareholders Equity | 7.64B |
| Shareholders Equity (USD) | 7.64B |
| Assets Non-Current | 3.23B |
| Total Debt (USD) | 2.48B |
| Deferred Revenue | 2.73B |
| Goodwill and Intangible Assets | 767.00M |
| Liabilities Non-Current | 2.83B |
| Trade and Non-Trade Payables | 10.55B |
| Tax Assets | 1.94B |
| Cash Flow |
| Net Cash Flow from Financing | 2.97B |
| Net Cash Flow / Change in Cash & Cash Equivalents | 4.10B |
| Issuance (Purchase) of Equity Shares | -1.08B |
| Issuance (Repayment) of Debt Securities | 483.00M |
| Net Cash Flow from Investing | -461.00M |
| Net Cash Flow - Investment Acquisitions and Disposals | -526.00M |
| Net Cash Flow from Operations | 1.71B |
| Effect of Exchange Rate Changes on Cash | -118.00M |
| Share Based Compensation | 410.00M |